Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SSX5 Protein (Transcript Variant 1) (Myc-DYKDDDDK Tag)

SSX5 Origine: Humain Hôte: HEK-293 Cells Recombinant > 80 % as determined by SDS-PAGE and Coomassie blue staining AbP, STD
N° du produit ABIN2732739
  • Antigène Voir toutes SSX5 Protéines
    SSX5 (Synovial Sarcoma, X Breakpoint 5 (SSX5))
    Type de proteíne
    Recombinant
    Attributs du protein
    Transcript Variant 1
    Origine
    Humain
    Source
    • 1
    • 1
    HEK-293 Cells
    Purification/Conjugué
    Cette SSX5 protéine est marqué à la Myc-DYKDDDDK Tag.
    Application
    Antibody Production (AbP), Standard (STD)
    Attributs du produit
    • Recombinant human SSX5 (transcript variant 1) protein expressed in HEK293 cells.
    • Produced with end-sequenced ORF clone
    Pureté
    > 80 % as determined by SDS-PAGE and Coomassie blue staining
    Top Product
    Discover our top product SSX5 Protéine
  • Indications d'application
    Recombinant human proteins can be used for:
    Native antigens for optimized antibody production
    Positive controls in ELISA and other antibody assays
    Commentaires

    The tag is located at the C-terminal.

    Restrictions
    For Research Use only
  • Concentration
    50 μg/mL
    Buffer
    25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
    Stock
    -80 °C
    Stockage commentaire
    Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
  • Antigène
    SSX5 (Synovial Sarcoma, X Breakpoint 5 (SSX5))
    Autre désignation
    Ssx5 (SSX5 Produits)
    Synonymes
    putative protein SSX6 Protein, synovial sarcoma, X breakpoint 5 Protein, SSX family member 5 Protein, LOC612524 Protein, SSX5 Protein
    Sujet
    The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneous humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. While some of the related SSX genes are involved in t(X18)(p11.2q11.2) translocations that are characteristically found in all synovial sarcomas, this gene does not appear to be involved in such translocations. Two transcript variants encoding distinct isoforms have been identified for this gene.
    Poids moléculaire
    26.1 kDa
    NCBI Accession
    NP_066295
Vous êtes ici:
Support technique